zamifenacin has been researched along with Colonic Diseases, Functional in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, FC; Goka, J; Houghton, LA; Rogers, J; Whorwell, PJ; Williams, NS | 1 |
1 trial(s) available for zamifenacin and Colonic Diseases, Functional
| Article | Year |
|---|---|
Zamifenacin (UK-76, 654) a potent gut M3 selective muscarinic antagonist, reduces colonic motor activity in patients with irritable bowel syndrome.
Topics: Adult; Aged; Colonic Diseases, Functional; Dioxoles; Double-Blind Method; Humans; Male; Middle Aged; Muscarinic Antagonists; Piperidines | 1997 |